Pharmafile Logo
Pharmafocus logo
Advanced Search

Janssen Biotech

Showing 3 posts of 3 posts found.

jj_2johnson_and_johnson

Johnson & Johnson’s Stelara receives FDA approval

September 27, 2016
Manufacturing and Production, Research and Development Janssen Biotech, Johnson & Johnson, Stelara

The drug is approved for use to treat the skin condition scaly plaque psoriasis and a type of arthritis associated …

News
abbvie_0

AbbVie’s Imbruvica gets US FDA okay as first-line treatment for CLL

March 7, 2016
Sales and Marketing AbbVie, Janssen, Janssen Biotech, US FDA, imbruvica

Drug maker AbbVie said the US Food and Drug Administration (FDA) has approved its Imbruvica (ibrutinib) as a first-line treatment …

News
nuevolution_logo

Nuevolution, Johnson & Johnson begin discovery collaboration

October 19, 2015
Manufacturing and Production, Research and Development Chemetics, Janssen Biotech, Nuevolution

Nuevolution and Janssen Biotech have entered into a collaboration which will use Nuevolution’s Chemetics drug discovery platform to facilitate discovery …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025